Vinnova grants one-carbon therapeutics money

by admin
mars 29, 2022

One-carbon therapeutics AB is granted 3,000,000 SEK from Sweden’s innovation agency Vinnova under the Medtech4Health and SweLife programs for further development of the MTHFD2 program.

Rekommenderade artiklar

One-carbon therapeutics AB management at ESMO to discuss the ODIN clinical phase 1/2 trial with potential clinical sites across Europe

One-carbon therapeutics AB is discussing the ODIN trial with several

Our Founder Prof Thomas Helleday wins the Anders Jahre’s price in Medicine

Read the article here.

One-carbon therapeutics AB is moving into new offices

In preparation and expansion for the upcoming clinical trial, we

Menu bar